We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$410M
AUM Growth
+$25.1M
Cap. Flow
+$1.82M
Cap. Flow %
0.44%
Top 10 Hldgs %
64.33%
Holding
164
New
15
Increased
61
Reduced
60
Closed
17

Sector Composition

Rank Sector Weight
1 Healthcare 13.4%
2 Technology 12.59%
3 Consumer Staples 4.8%
4 Communication Services 2.86%
5 Materials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
26
Deere & Co
DE
$166B
$2.38M 0.58%
4,687
-1,486
-24% -$728K
ABT icon
27
Abbott
ABT
$187B
$2.29M 0.56%
16,808
+4,126
+33% +$544K
MRK icon
28
Merck
MRK
$317B
$2.19M 0.53%
27,671
-4,233
-13% -$336K
BDX icon
29
Becton Dickinson
BDX
$48.8B
$2.13M 0.52%
12,389
+4,337
+54% +$795K
GEHC icon
30
GE HealthCare
GEHC
$31.8B
$2.07M 0.51%
28,009
+11,609
+71% +$808K
MOS icon
31
The Mosaic Company
MOS
$7.46B
$1.96M 0.48%
53,757
-54,357
-50% -$1.74M
SYK icon
32
Stryker
SYK
$129B
$1.94M 0.47%
4,901
+377
+8% +$141K
TMO icon
33
Thermo Fisher Scientific
TMO
$214B
$1.76M 0.43%
4,349
+1,772
+69% +$741K
CTVA icon
34
Corteva
CTVA
$51.3B
$1.68M 0.41%
22,557
-11,858
-34% -$790K
AMGN icon
35
Amgen
AMGN
$219B
$1.65M 0.4%
5,905
+253
+4% +$71.7K
CVS icon
36
CVS Health
CVS
$123B
$1.57M 0.38%
22,753
+11,126
+96% +$730K
GILD icon
37
Gilead Sciences
GILD
$162B
$1.57M 0.38%
14,150
+4,080
+41% +$434K
LH icon
38
Labcorp
LH
$25.6B
$1.56M 0.38%
5,956
+147
+3% +$35.8K
BMY icon
39
Bristol-Myers Squibb
BMY
$131B
$1.51M 0.37%
32,606
+6,632
+26% +$326K
BAX icon
40
Baxter International
BAX
$14B
$1.47M 0.36%
48,708
+10,104
+26% +$306K
UNH icon
41
UnitedHealth
UNH
$367B
$1.37M 0.33%
4,399
+1,134
+35% +$433K
BSX icon
42
Boston Scientific
BSX
$71.4B
$1.33M 0.32%
12,360
+1,571
+15% +$159K
VZ icon
43
Verizon
VZ
$195B
$1.32M 0.32%
30,475
-1,451
-5% -$62.8K
AMZN icon
44
Amazon
AMZN
$2.94T
$1.31M 0.32%
5,961
+1,641
+38% +$325K
T icon
45
AT&T
T
$162B
$1.29M 0.31%
44,554
-2,643
-6% -$72.8K
DELL icon
46
Dell
DELL
$283B
$1.23M 0.3%
10,025
-2,491
-20% -$255K
CL icon
47
Colgate-Palmolive
CL
$74.1B
$1.17M 0.29%
12,888
-11,111
-46% -$1.01M
DGX icon
48
Quest Diagnostics
DGX
$26.3B
$1.12M 0.27%
6,219
+571
+10% +$99.2K
VRTX icon
49
Vertex Pharmaceuticals
VRTX
$123B
$1.11M 0.27%
2,489
+494
+25% +$228K
CMCSA icon
50
Comcast
CMCSA
$89.3B
$1.1M 0.27%
30,707
+1,558
+5% +$53.9K

Similar funds

Humankind Investments's Q2 2025 Portfolio in Review

As of Q2 2025, Humankind Investments held 164 positions worth $410M, up 6.5% from $385M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Humankind Investments's Q2 2025 filing shows 15 new, 61 increased, 60 reduced and 17 closed positions. Its largest new stake was Aecom: 3,204 shares worth $362K. The largest sale was Procter & Gamble, an estimated $3.51M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Staples.

  • Humankind Investments's largest Q2 2025 buy was Aecom: 3,204 shares worth $362K.
  • Humankind Investments added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2025, an estimated $4.99M increase.
  • Humankind Investments's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $3.51M.
  • Humankind Investments fully exited iShares TIPS Bond ETF in Q2 2025, selling an estimated $2.83M.
  • Humankind Investments's ten largest holdings make up 64% of its $410M portfolio in Q2 2025.
  • Humankind Investments opened 15 new positions and closed 17 in Q2 2025.
  • Humankind Investments's portfolio value rose 6.5% quarter-over-quarter to $410M.

Based on Humankind Investments's 13F filing for Q2 2025, filed 14 Aug 2025.